A detailed history of Rhumbline Advisers transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 32,997 shares of ARCT stock, worth $545,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,997
Previous 34,186 3.48%
Holding current value
$545,440
Previous $832,000 8.05%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$18.08 - $25.38 $21,497 - $30,176
-1,189 Reduced 3.48%
32,997 $765,000
Q2 2024

Aug 01, 2024

SELL
$24.35 - $44.39 $82,351 - $150,126
-3,382 Reduced 9.0%
34,186 $832,000
Q1 2024

May 09, 2024

BUY
$31.23 - $42.99 $44,003 - $60,572
1,409 Added 3.9%
37,568 $1.27 Million
Q4 2023

Feb 08, 2024

SELL
$17.71 - $32.97 $4,923 - $9,165
-278 Reduced 0.76%
36,159 $1.14 Million
Q3 2023

Nov 09, 2023

BUY
$25.44 - $37.35 $17,172 - $25,211
675 Added 1.89%
36,437 $930,000
Q2 2023

Aug 08, 2023

BUY
$23.94 - $32.36 $128,390 - $173,546
5,363 Added 17.64%
35,762 $1.03 Million
Q1 2023

May 11, 2023

BUY
$14.72 - $23.97 $17,943 - $29,219
1,219 Added 4.18%
30,399 $729,000
Q4 2022

Feb 14, 2023

BUY
$14.14 - $23.06 $12,938 - $21,099
915 Added 3.24%
29,180 $495,000
Q3 2022

Nov 10, 2022

BUY
$13.05 - $22.13 $33,499 - $56,807
2,567 Added 9.99%
28,265 $419,000
Q2 2022

Aug 11, 2022

SELL
$12.26 - $31.17 $15,067 - $38,307
-1,229 Reduced 4.56%
25,698 $404,000
Q1 2022

May 12, 2022

SELL
$17.64 - $39.57 $42,547 - $95,442
-2,412 Reduced 8.22%
26,927 $726,000
Q4 2021

Feb 10, 2022

SELL
$34.2 - $47.56 $10,362 - $14,410
-303 Reduced 1.02%
29,339 $1.09 Million
Q3 2021

Nov 12, 2021

BUY
$27.88 - $58.25 $27,183 - $56,793
975 Added 3.4%
29,642 $1.42 Million
Q2 2021

Aug 05, 2021

BUY
$25.79 - $42.11 $187,931 - $306,855
7,287 Added 34.08%
28,667 $970,000
Q1 2021

May 06, 2021

SELL
$38.75 - $86.92 $133,803 - $300,134
-3,453 Reduced 13.9%
21,380 $883,000
Q4 2020

Feb 10, 2021

BUY
$34.61 - $123.66 $275,807 - $985,446
7,969 Added 47.25%
24,833 $1.08 Million
Q3 2020

Nov 12, 2020

SELL
$37.49 - $63.19 $17,207 - $29,004
-459 Reduced 2.65%
16,864 $723,000
Q2 2020

Aug 13, 2020

BUY
$12.66 - $58.27 $219,309 - $1.01 Million
17,323 New
17,323 $810,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.